相似文献
1
Follow-up recommendations for colon cancer.
Clin Colon Rectal Surg. 2005 Aug;18(3):232-43. doi: 10.1055/s-2005-916284.
2
Follow-up after curative resection of colorectal cancer: a meta-analysis.
Dis Colon Rectum. 2007 Nov;50(11):1783-99. doi: 10.1007/s10350-007-9030-5.
3
Follow-up strategies after curative resection of colorectal cancer.
Semin Oncol. 2003 Jun;30(3):349-60. doi: 10.1016/s0093-7754(03)00095-2.
4
Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model.
World J Surg. 2004 Jun;28(6):563-9. doi: 10.1007/s00268-004-7256-0.
5
Follow-up strategies for patients treated for non-metastatic colorectal cancer.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD002200. doi: 10.1002/14651858.CD002200.pub2.
6
The role of postoperative surveillance in colorectal cancer.
Clin Colon Rectal Surg. 2007 Aug;20(3):249-54. doi: 10.1055/s-2007-984869.
7
Intensive Follow-Up After Curative Surgery for Colorectal Cancer.
Acta Med Port. 2017 Sep 29;30(9):633-641. doi: 10.20344/amp.7889.
8
A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
PLoS One. 2016 Oct 4;11(10):e0163264. doi: 10.1371/journal.pone.0163264. eCollection 2016.
9
Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial.
Surg Oncol. 2004 Aug-Nov;13(2-3):119-24. doi: 10.1016/j.suronc.2004.08.005.
10
Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts.
Langenbecks Arch Surg. 2000 Oct;385(6):412-20. doi: 10.1007/s004230000144.
引用本文的文献
1
The Association between Colorectal Cancer and Colonoscopic Conditions in Saudi Patients: A 10-Year Cross-Sectional-Retrospective Study.
Ethiop J Health Sci. 2022 Nov;32(6):1157-1166. doi: 10.4314/ejhs.v32i6.13.
2
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review.
Vaccines (Basel). 2022 Oct 16;10(10):1727. doi: 10.3390/vaccines10101727.
3
Cancer Immunoprevention: Current Status and Future Directions.
Arch Immunol Ther Exp (Warsz). 2021 Feb 27;69(1):3. doi: 10.1007/s00005-021-00604-x.
4
Is There Still a Role for Physical Consultation in Colorectal Cancer Surveillance?
J Gastrointest Surg. 2021 Jan;25(1):290-292. doi: 10.1007/s11605-020-04774-5. Epub 2020 Aug 31.
5
Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer.
Acta Inform Med. 2020 Jun;28(2):119-123. doi: 10.5455/aim.2020.28.119-123.
6
Factors associated with the survival of colorectal cancer in Mexico.
Intest Res. 2020 Jul;18(3):315-324. doi: 10.5217/ir.2019.09179. Epub 2020 May 19.
7
Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal Cancer.
J Clin Med. 2020 Feb 15;9(2):533. doi: 10.3390/jcm9020533.
8
The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
BMC Cancer. 2019 May 3;19(1):418. doi: 10.1186/s12885-019-5613-5.
9
Total caseload of a colorectal surgical unit: baseline measurement and identification of areas for efficiency gains.
Int J Colorectal Dis. 2016 Jun;31(6):1141-8. doi: 10.1007/s00384-016-2556-z. Epub 2016 Mar 16.
10
Postcolectomy Peritoneal Environment Increases Colon Cancer Cell Migration Capacity.
Gastroenterol Res Pract. 2016;2016:2540397. doi: 10.1155/2016/2540397. Epub 2015 Dec 27.
本文引用的文献
1
Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model.
World J Surg. 2004 Jun;28(6):563-9. doi: 10.1007/s00268-004-7256-0.
2
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.
Ann Oncol. 2004 Jun;15(6):933-9. doi: 10.1093/annonc/mdh217.
3
Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer.
Dis Colon Rectum. 2004 Jun;47(6):807-17. doi: 10.1007/s10350-004-0519-x. Epub 2004 May 4.
4
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
J Clin Oncol. 2004 Apr 15;22(8):1420-9. doi: 10.1200/JCO.2004.05.041. Epub 2004 Mar 8.
5
Follow-up for patients with colorectal cancer after curative-intent primary treatment.
J Clin Oncol. 2004 Apr 15;22(8):1363-5. doi: 10.1200/JCO.2004.01.948. Epub 2004 Mar 8.
6
Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer.
BMJ. 2004 Jan 10;328(7431):81. doi: 10.1136/bmj.328.7431.81.
7
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.
BMC Cancer. 2003 Oct 6;3:26. doi: 10.1186/1471-2407-3-26.
8
THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM.
Am J Surg. 1964 Dec;108:826-9. doi: 10.1016/0002-9610(64)90041-8.
9
Follow-up strategies after curative resection of colorectal cancer.
Semin Oncol. 2003 Jun;30(3):349-60. doi: 10.1016/s0093-7754(03)00095-2.
10
Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.
Oncology. 2003;64(2):131-8. doi: 10.1159/000067772.
Zotero 插件